<DOC>
	<DOCNO>NCT01619332</DOCNO>
	<brief_summary>This study three part study ass safety efficacy LEZ763 normal healthy volunteer patient Type 2 Diabetes .</brief_summary>
	<brief_title>Clinical Safety , Tolerability , Pharmacokinetics Pharmacodynamics LEZ763</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Inclusion criterion : All subject : ( suggest reduce duplication ) Male female age 1865 yr , Subjects must weigh least 50 kg participate study . Body mass index ( BMI ) must within range 1837 kg/m2 ( inclusive Only postmenopausal female female subject report surgical sterilization ( woman without child bear potential ) allow study . Subjects stable conventional sleepwake cycle Normal Healthy Volunteers Healthy male female subject , must good health ( determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test Screening ) . Type II Diabetic Patients Type 2 diabetes diagnosed American Diabetes Association criteria least 3 month prior screen . Patients either drug naïve stable dose metformin ( stable dose least 4 week prior Screening ) . The metformin dose remain constant course study . HbA1c 6.5 9.5 % inclusive screening Exclusion criterion : All subject : Smokers ( use tobacco product previous 3 month ) . Donation loss 400 mL blood within 8 week prior first dose , longer required local regulation . Significant illness within two week prior dose . Have ( history ) drug alcohol abuse within 12 month prior dose evidence abuse indicate laboratory assay conduct screen baseline evaluation Normal Healthy Volunteers • History diabetes , adrenal disorder . Type II Diabetic Patients Type 1 diabetes mellitus ; positive antiGAD antibody ; acquire secondary form diabetes result pancreatic surgery/injury , cystic fibrosis relate diabetes Evidence clinically significant diabetic complication ( nephropathy , retinopathy , neuropathy ) Other protocol define inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Healthy volunteer ,</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Glucose</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>